BS Identity and Score for Nplate (Amgen)

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Nplate (Amgen) (nplate.com)

https://nplate.com 📍 Industry: Medical Devices, Pharma & Biotech
42 BS / 100

Nplate.com is a textbook case of ‘Pharma-Sloppy’—it presents the legal appearance of a high-substance medical site while containing ‘Lorem Ipsum’ placeholder text in its clinical reference section. By claiming 5 clinical studies but providing ‘TK Drem ipsum’ as the source, the site effectively defaults on its promise of scientific transparency. It is a high-authority product wrapped in a low-effort, technically deficient digital shell.

Info Density Power-words vs. Substance ratio.
10
33% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
2
10% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
15
75% BS
Commodity Fingerprint Detection of industry clichés/templates.
3
20% BS
Identity & Authority Expert verifiability & Schema depth.
12
80% BS

Immediately replace the ‘TK Drem ipsum’ placeholder text in the References section with actual citations to peer-reviewed studies. Implement MedicalWebPage and Drug schema.org markup to provide machine-readable authority and clinical indication data. Add direct, verifiable links to the 5 clinical studies mentioned on the ‘Why Nplate’ page to ClinicalTrials.gov. Remove the review counts from the metadata if there are no actual reviews to display, as this currently triggers trust theatre warnings.

Info Density Power-words vs. Substance ratio.
10 Impact Weight: 30 / 100
33% BS

While the site provides significant technical detail regarding side effects and dosage, its Information Density is compromised by blatant placeholder content. The primary H1 on the homepage ‘Strive for rapid stability and reach for remission’ uses standard clinical power words, but the body text eventually fails forensic inspection. Specifically, the ‘References’ section on the homepage and several sub-pages contains the text ‘TK Drem ipsum dolor sit amet,’ indicating that clinical substance was intended but never actually inserted. This creates a high ratio of fluff-to-substance in the areas where scientific rigor is most expected.

AI only sees the HTML that arrives on first response — everything else is invisible. Expose your real text only footprint and find out which parts of your site never reach an AI crawler at all.

Semantic Coherence Homepage promise vs. Sub-page reality.
2 Impact Weight: 20 / 100
10% BS

The homepage promises ‘rapid stability and remission’ which the sub-pages attempt to support through explanations of the Mechanism of Action. On the ‘Platelet Booster’ page, the content shifts to lifestyle benefits like ‘Eat when and what you want,’ which aligns well with the weekly injection benefit. However, there is a minor disconnect where the homepage suggests a reach for remission, but the ‘Nplate 101’ page clarifies that for most, it only ‘may lead to’ remission for ‘some adults.’ This creates a slight gap between the hero-section optimism and the clinical reality described in the sub-pages.

Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.

Trust & Proof Verifiable evidence vs. Trust Theatre.
15 Impact Weight: 20 / 100
75% BS

The site exhibits clear trust theatre through the inclusion of ‘review_count’ metadata (1 on the homepage, 3 on the support page) without any corresponding user-generated content or verifiable patient reviews in the text. Furthermore, the ‘proof_links_count’ is technically present, but since the link leads to ‘TK Drem ipsum’ placeholder text, it constitutes a failed proof path. This combination of metadata-level trust signals and broken/faked citations is a significant red flag for BS detection.

The proof density is remarkably low for a pharmaceutical website, as the verifiable evidence is trapped behind placeholder text. While the site mentions the 50,000 platelet count threshold, it provides zero outbound links to the actual clinical data used to support its primary stability claims. The ratio of vague assertions like ‘Nplate is here for you’ to hard, verifiable data points is heavily skewed toward marketing fluff.

To evaluate URL identity stability and multilingual coherence, review the Yoast Identity Stability audit. View the Yoast Identity Stability Audit for a practical example of canonical alignment and language layer integrity.

Commodity Fingerprint Detection of industry clichés/templates.
3 Impact Weight: 15 / 100
20% BS

The value proposition is relatively unique because it focuses on a specific molecule (romiplostim) and its role as a TPO receptor agonist, rather than generic ‘health solutions.’ However, the site uses common pharma cliches like ‘innovation for life’ and ‘personalized dosing’ found in the industry dictionary. The layout follows a rigid template fingerprint common to Amgen products, including ‘Important Safety Information’ blocks that appear on every page. While the product is differentiated, the marketing language used to describe the ‘Support’ and ‘Videos’ sections is largely interchangeable with any other chronic condition drug site.

Identity & Authority Expert verifiability & Schema depth.
12 Impact Weight: 15 / 100
80% BS

There is a complete absence of structured data (JSON-LD) across all analyzed pages, leaving a massive gap in machine-readable authority. While Amgen is a known entity, the site itself fails to link to any specific experts, researchers, or clinical leads using Person schema or sameAs links. The technical implementation is sloppy for a medical site, evidenced by the broken heading hierarchy on the support page where H4 questions are repeated twice in the source data. This lack of technical precision undermines the ‘science-driven’ authority the brand claims to possess.

The site makes bold claims about being ‘proven to boost and sustain platelets’ based on ‘5 clinical studies,’ yet fails to provide actual citations for these studies. Instead of linking to peer-reviewed results or ClinicalTrials.gov, the site relies on a placeholder reference section. This creates a disconnect where the ‘Signal’ of clinical success is high, but the ‘Substance’ provided to the user is currently non-existent or faked.

Medical Devices, Pharma & Biotech BS: Nplate (Amgen) (nplate.com)

BS: 42/ 100

The website perfectly aligns with the Pharma and Biotech industry, specifically focusing on the treatment of Immune Thrombocytopenia (ITP) using romiplostim. The presence of mandatory Important Safety Information and clinical terminology like thrombopoietin (TPO) confirms its categorization.

A page with no inbound links is invisible to AI, no matter how strong the content is. Open the Internal Linking Framework Guide to learn how link driven relationships shape retrieval, authority, and entity grouping.

“The score of 42 is primarily driven by the 'Trust and Proof' and 'Identity and Authority' pillars. The discovery of placeholder text in the reference section (TK Drem ipsum) significantly penalized the site's credibility, as did the total absence of structured schema data. The site avoided a higher score only because the mandatory Safety Information provides a baseline of technical substance required by law.”

To understand and learn thinking like AI, visit our educational environment (Nplate (Amgen) example) that uses the same data this audit was generated from, and try it yourself.
Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY